BNZI - Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket | Benzinga
Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading.
LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th.
LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Harpoon Therapeutics, Inc.(NASDAQ: HARP) gained 98.6% to $20.95 in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.
- Vincerx Pharma, Inc. (NASDAQ: VINC) shares rose 56.3% to $1.86 in pre-market trading after the company announced compelling clinical efficacy of enitociclib in combination with venetoclax and prednisone in lymphoma.
- Spectaire Holdings Inc. (NASDAQ: SPEC) shares gained 46.6% to $2.48 in pre-market trading after gaining 7% on Friday.
- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares gained 36.5% to $3.40 in pre-market trading after jumping over 10% on Friday.
- Vision Marine Technologies Inc. (NASDAQ: